431 related articles for article (PubMed ID: 17713641)
1. In vitro mating of Colombian isolates of the Cryptococcus neoformans species complex.
Escandón P; Ngamskulrungroj P; Meyer W; Castañeda E
Biomedica; 2007 Jun; 27(2):308-14. PubMed ID: 17713641
[TBL] [Abstract][Full Text] [Related]
2. Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia.
Escandón P; Sánchez A; Martínez M; Meyer W; Castañeda E
FEMS Yeast Res; 2006 Jun; 6(4):625-35. PubMed ID: 16696659
[TBL] [Abstract][Full Text] [Related]
3. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients.
Feng X; Yao Z; Ren D; Liao W; Wu J
FEMS Yeast Res; 2008 Sep; 8(6):930-8. PubMed ID: 18671745
[TBL] [Abstract][Full Text] [Related]
4. Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility.
Liaw SJ; Wu HC; Hsueh PR
Clin Microbiol Infect; 2010 Jun; 16(6):696-703. PubMed ID: 19694765
[TBL] [Abstract][Full Text] [Related]
5. Mating types and serotypes of Cryptococcus neoformans isolated in Japan.
Hironaga M; Ikeda R; Fukazawa Y; Watanabe S
Sabouraudia; 1983 Mar; 21(1):73-8. PubMed ID: 6342176
[TBL] [Abstract][Full Text] [Related]
6. [Mating types, sexual reproduction and ploidy in fungi: effects on virulence].
Cerikçioğlu N
Mikrobiyol Bul; 2009 Jul; 43(3):507-13. PubMed ID: 19795629
[TBL] [Abstract][Full Text] [Related]
7. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.
Viviani MA; Cogliati M; Esposto MC; Lemmer K; Tintelnot K; Colom Valiente MF; Swinne D; Velegraki A; Velho R;
FEMS Yeast Res; 2006 Jun; 6(4):614-9. PubMed ID: 16696657
[TBL] [Abstract][Full Text] [Related]
9. Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates.
Nielsen K; Cox GM; Wang P; Toffaletti DL; Perfect JR; Heitman J
Infect Immun; 2003 Sep; 71(9):4831-41. PubMed ID: 12933823
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.
Aminnejad M; Diaz M; Arabatzis M; Castañeda E; Lazera M; Velegraki A; Marriott D; Sorrell TC; Meyer W
Mycopathologia; 2012 Jun; 173(5-6):337-46. PubMed ID: 22081254
[TBL] [Abstract][Full Text] [Related]
11. First environmental isolation of Cryptococcus gattii serotype B, from Cúcuta, Colombia.
Firacative C; Torres G; Rodríguez MC; Escandón P
Biomedica; 2011 Mar; 31(1):118-23. PubMed ID: 22159490
[TBL] [Abstract][Full Text] [Related]
12. Serotype identification of Cryptococcus neoformans by multiplex PCR.
Ito-Kuwa S; Nakamura K; Aoki S; Vidotto V
Mycoses; 2007 Jul; 50(4):277-81. PubMed ID: 17576319
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates.
Tintelnot K; Lemmer K; Losert H; Schär G; Polak A
Mycoses; 2004 Dec; 47(11-12):455-64. PubMed ID: 15601449
[TBL] [Abstract][Full Text] [Related]
14. Electrophoretic karyotyping of Cryptococcus neoformans AD-hybrid strains.
Esposto MC; Cogliati M; Tortorano AM; Viviani MA
Mycoses; 2009 Jan; 52(1):16-23. PubMed ID: 18498305
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans var. gattii in India.
Padhye AA; Chakrabarti A; Chander J; Kaufman L
J Med Vet Mycol; 1993; 31(2):165-8. PubMed ID: 8509953
[TBL] [Abstract][Full Text] [Related]
16. Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya.
Bii CC; Makimura K; Abe S; Taguchi H; Mugasia OM; Revathi G; Wamae NC; Kamiya S
Mycoses; 2007 Jan; 50(1):25-30. PubMed ID: 17302744
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and antifungal susceptibility of Cryptococcus neoformans strains collected from a single institution in Lima, Peru.
Bejar V; Tello M; García R; Guevara JM; Gonzales S; Vergaray G; Valencia E; Abanto E; Ortega-Loayza AG; Hagen F; Gutierrez EL
Rev Iberoam Micol; 2015; 32(2):88-92. PubMed ID: 25556051
[TBL] [Abstract][Full Text] [Related]
18. Serotypes and mating types of clinical strains of Cryptococcus neoformans isolated in Taiwan.
Hsu MM; Chang JC; Yokoyama K; Nishimura K; Miyaji M
Mycopathologia; 1994 Feb; 125(2):77-81. PubMed ID: 8028646
[TBL] [Abstract][Full Text] [Related]
19. [Phenotype characterization of environmental Cryptococcus neoformans isolates].
Huérfano S; Cepero MC; Castañeda E
Biomedica; 2003 Sep; 23(3):328-40. PubMed ID: 14582336
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of Cryptococcus neoformans varieties and Cryptococcus gattii using CAP59-based loop-mediated isothermal DNA amplification.
Lucas S; da Luz Martins M; Flores O; Meyer W; Spencer-Martins I; Inácio J
Clin Microbiol Infect; 2010 Jun; 16(6):711-4. PubMed ID: 19694768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
